SEC Form 4 · accession 0001493152-17-004362
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J Booth
Director
Period of report
Jan 1, 2017
Accepted (ET)
Apr 25, 2017 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1 | $2.05 | Jan 1, 2017 | A | 26,780 | A | — | Jan 1, 2027 | Common Stock | 26,780 | 95,333 | D |
Explanation of responses
- F1Vests in four (4) successive equal quarterly installments over the one-year period measured from the date of grant.